Cirrhosis of the liver
267 results
1 - 100Cirrhosis of the liver
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease New
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease New
Bezafibrate for primary biliary cirrhosis: Cochrane systematic review
Colchicine for primary biliary cirrhosis Edited (no change to conclusions)
Ursodeoxycholic acid for primary biliary cirrhosis New search for studies and content updated (no change to conclusions)
Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis: Cochrane systematic review
Methotrexate for primary biliary cirrhosis New search for studies and content updated (no change to conclusions)
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
D-penicillamine for primary biliary cirrhosis: Cochrane systematic review
Colchicine for primary biliary cirrhosis
D-penicillamine for primary biliary cirrhosis
Useful clinical indicators to diagnose cirrhosis
Hormone replacement for osteoporosis in women with primary biliary cirrhosis: Cochrane systematic review
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis New
Glucocorticosteroids for primary biliary cirrhosis: Cochrane systematic review
Primary sclerosing cholangitis
Bisphosphonates for osteoporosis in primary biliary cirrhosis: Cochrane systematic review
Cyclosporin A for primary biliary cirrhosis: Cochrane systematic review
Methotrexate for primary biliary cirrhosis
Assessing a patient with an abnormal liver function test result
Treatment of hepatocellular carcinoma associated with cirrhosis
Antioxidant supplements for liver diseases: Cochrane systematic review
Cyclosporin A for primary biliary cirrhosis
Glucocorticosteroids for primary biliary cirrhosis
Somatostatin analogues for acute bleeding oesophageal varices Stable (no update expected for reasons given in 'What's new')
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): Cochrane systematic review
Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis New
Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta‐analysis New
Autoimmune hepatitis
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis: Cochrane systematic review
Platelet count/spleen diameter ratio in predicting the presence of oesophageal varices in patients with cirrhosis
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis New
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome: Cochrane systematic review
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis: Cochrane systematic review
Curable causes of memory-related symptoms and diseases
Bile acids for liver‐transplanted patients New search for studies and content updated (no change to conclusions)
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis Edited (no change to conclusions)
Chlorambucil for patients with primary biliary cirrhosis: Cochrane systematic review
Glucocorticosteroids for primary sclerosing cholangitis: Cochrane systematic review
Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis New
Organ transplant recipient in primary health care
Skin colour changes and pigmentary disorders
Ultrasonographic examinations
Anabolic-androgenic steroids for alcoholic liver disease: Cochrane systematic review
Primary biliary cholangitis
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
Azathioprine for primary biliary cirrhosis: Cochrane systematic review
Branched‐chain amino acids for people with hepatic encephalopathy Edited (no change to conclusions)
Clinical factors predict death in patients with cirrhosis + UGI bleeding
Hyponatraemia
Terlipressin for acute esophageal variceal hemorrhage Edited (no change to conclusions)
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: Cochrane systematic review
The icteric patient
Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices New
Antioxidant supplements for liver diseases
Haemochromatosis
Vitamin E improves histology of NASH, patient-oriented benefit unknown
Unintentional weight loss in adults